PRT054021

PRT054021 · Portola Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRT054021, covering 2017-12-15 to 2017-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT) [Phase 2]

See pricing